Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer

Go back to Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
(NASDAQ: TENX) Delayed: 1.78 -0.12 (6.32%)
Previous Close $1.90    52 Week High $3.40 
Open $1.86    52 Week Low $1.34 
Day High $1.88    P/E N/A 
Day Low $1.76    EPS $0.00 
Volume 4,063,649